Dermatology evaluation for cutaneous immune related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition: Supplemental File 1
Published: 12 September 2022| Version 1 | DOI: 10.17632/7vd5tg3ty6.1
Contributors:
Ted Jacoby, Nishi Shah, Maria Asdourian, Leah Thompson, Tracey Otto, Nicole LeBoeuf, Yevgeniy Semenov, Christopher Dee, Kerry Reynolds, Steven ChenDescription
This file includes additional details on study methodology.
Files
Categories
Oncology, Medical Dermatology